# A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years

> **NCT02263469** · PHASE3 · COMPLETED · sponsor: **Bio Products Laboratory**

## Conditions studied

- Haemophilia B

## Interventions

- **BIOLOGICAL:** Replenine®-VF (High Purity Factor IX)

## Key facts

- **NCT ID:** NCT02263469
- **Lead sponsor:** Bio Products Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-07
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263469, "A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02263469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*